EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development

Passley Hargrove-Grimes, Lucie A Low, Danilo A Tagle

Cells Tissues Organs · 2022 · 211 (3) · 269-281

DOI: 10.1159/000517422 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells Tissues Organs, online erschienen am 11.08.2021. Verfasst von Passley Hargrove-Grimes und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA, passley.hargrove@nih.gov. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, Microfluidics. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microphysiological systems (MPS) or tissue chips/organs-on-chips are novel in vitro models that emulate human physiology at the most basic functional level. In this review, we discuss various hurdles to widespread adoption of MPS technology focusing on issues from multiple stakeholder sectors, e.g., academic MPS developers, commercial suppliers of platforms, the pharmaceutical and biotechnology industries, and regulatory organizations. Broad adoption of MPS technology has thus far been limited by a gap in translation between platform developers, end-users, regulatory agencies, and the pharmaceutical industry. In this brief review, we offer a perspective on the existing barriers and how end-users may help surmount these obstacles to achieve broader adoption of MPS technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lab-On-A-Chip DevicesMicrofluidicsDrug DevelopmentHumans

Stichwörter der Autor:innen

BioengineeringDrug developmentInduced pluripotent stem cellsMicrofluidicsMicrophysiological systems

Autor:innen und Institutionen

  • National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA, passley.hargrove@nih.gov.
  • National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Hargrove-Grimes, P., Low, L. A., & Tagle, D. A. (2022). Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development. Cells Tissues Organs, 211(3), 269-281. https://doi.org/10.1159/000517422

Vancouver

Hargrove-Grimes P, Low LA, Tagle DA. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development. Cells Tissues Organs. 2022;211(3):269-281. doi:10.1159/000517422

BibTeX
@article{HargroveGrimes2022,
  author = {Hargrove-Grimes, Passley and Low, Lucie A and Tagle, Danilo A},
  title = {Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development},
  journal = {Cells Tissues Organs},
  year = {2022},
  volume = {211},
  number = {3},
  pages = {269--281},
  doi = {10.1159/000517422}
}
Kostenlos starten →